 PHILADELPHIA, April 18, 2022 GLOBE NEWSWIRE -- Century Therapeutics NASDAQ: IPSC, an innovative biotechnology company developing induced pluripotent stem cell iPSC-derived cell therapies in immuno-oncology, today announced that members of the management team will present at the virtual Chardan Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 25, 2022, at 9:30 AM ET. 